Efficacy and Safety of Pulse Magnetic Therapy System in Insomnia Disorder: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.

OBJECTIVE: This study's objective is to assess the efficacy and safety of Pulsed Magnetic Therapy System (PMTS) in improving insomnia disorder. METHODS: Participants with insomnia disorder were randomly assigned to receive either PMTS or sham treatment for four weeks (n= 153; PMTS: 76, sham: 77). Primary outcomes are the Insomnia Severity Index (ISI) scores at week 0 (baseline), 1, 2, 3, 4 (treatment), and 5 (follow-up). Secondary outcomes are the Pittsburgh Sleep Quality Index at baseline and week 4, and weekly sleep diary-derived values for sleep latency, sleep efficiency, real sleep time, waking after sleep onset, and sleep duration. RESULTS: The ISI scores of the PMTS group and the sham group were 7.13±0.50, 11.07±0.51 at week 4, respectively. There was a significant group×time interaction for ISI (F3.214, 485.271=24.25, p<0.001, ηp 2=0.138). Only the PMTS group experienced continuous improvement throughout the study; in contrast, the sham group only experienced a modest improvement after the first week of therapy. At the end of the treatment and one week after it, the response of the PMTS group were 69.7% (95% confidence interval [CI]: 58.6%-79.0%), 75.0% (95% CI: 64.1%-83.4%), respectively, which were higher than the response of the sham group (p<0.001). For each of the secondary outcomes, similar group×time interactions were discovered. The effects of the treatment persisted for at least a week. CONCLUSION: PMTS is safe and effective in improving insomnia disorders.

Protective effect of ZYMT, a traditional Chinese patent medicine in a mouse model of retinitis pigmentosa.

Retinitis pigmentosa (RP) is the most common genetic disorder that causes blindness. At present, there exists no remedy for the disease. The aim of the current research was to investigate the protective effect of Zhangyanming Tablets (ZYMT) in a mouse model of RP, and explore the underlying mechanism. Eighty RP mice were randomly divided into two groups. The mice in ZYMT group were administered with ZYMT suspension(0.0378 g/mL), while the mice in model group were given the same volume of distilled water. At day 7 and day 14 after intervention, electroretinogram (ERG), fundus photography, and histological examination were used to assess the retinal function and structure. TUNEL, immunofluorescence and qPCR were used to evaluate cell apoptosis and expressions of Sirt1, Iba1, Bcl-2, Bax and Caspase-3. A significantly shortened latency of ERG waves was observed in ZYMT-treated mice, in comparison to those in the model group (P < 0.05). Histologically, ultrastructure of the retina was better preserved, and the outer nuclear layer (ONL) exhibited marked increase in thickness and cell count in ZYMP group (P < 0.05). The apoptosis rate was decreased markedly in ZYMT group. Immunofluorescence analysis showed that the expressions of Iba1 and Bcl-2 in the retina were increased, Bax and Caspase-3 were decreased after ZYMT intervention, while the qPCR revealed that the expressions of Iba1 and Sirt1 were significantly increased (P < 0.05). This study indicated that ZYMT has protective effect on retinal function and morphology of inherited RP mice in the early stage, possibly mediated via the regulation of antioxidant and anti-/pro-apoptotic factors expressions.

[Effects of tree species identity and diversity on young tree growth in a south subtropical plantation]. / æ ‘ç§åŠå¤šæ ·æ€§ç»„é å¯¹å—äºšçƒ­å¸¦äººå·¥æž—æ—©æœŸæ ‘æœ¨ç”Ÿé•¿çš„å½±å“.

To select the tree species assembly model for improving the productivity in south subtropical plantations, we carried out an experiment following a random block design with eight native tree species across a richness gradient of 1, 2, 4, and 6 species. The effects of tree species diversity and species mixing with different functional identities on the young tree growth were investigated in the 5th year of the experiment. The results showed that tree growth was not positively correlated with tree species richness. The growth of fast-growing tree species (Pinus massoniana and Mytilaria laosensis) in the monoculture was 2.5-4.5 times of the valuable broadleaved tree species (Castanopsis hystrix and Erythrophleum fordii) monoculture. Tree growth was significantly increased by 51.5%-132.8% in the conifer and broadleaved tree species mixing plantations and in the fast-growing and nitrogen fixation tree species mixing plantations, when two tree species or four tree species were mixed. There was no significant difference in tree growth among different tree species mixed types, when six tree species were mixed. The contents of soil nitrogen, phosphorus and organic matter were the main factors affecting tree growth. The results indicated that young tree growth could be improved through the selecting conifer and broadleaved tree species mixing, fast-growing and nitrogen fixation tree species mixing in south subtropical plantations.

Tracking the environmental fate of fipronil and three of its metabolites in garlic based on sampling rate-corrected in vivo solid phase microextraction combined with gas chromatography-mass spectrometry.

In this study, a sampling rate-corrected in vivo solid-phase microextraction-gas chromatography-mass spectrometry method (SR-in vivo SPME-GC-MS) was constructed to simultaneously detect fipronil and three of its metabolites in garlic, and their environmental behavior was long-term monitored in in vivo mode. All of three fipronil metabolites were more difficult to degrade than the parent pesticide. The final degradation rates of the metabolites in garlic were in the range of 4.4%-25.1%, much lower than that of the parent (78.6%-85.8%). While their total residues amount was about 3 times as high as fipronil, exceeding the maximum residue limits regulated by China and the European Union. The steady-state concentrations of fipronil and its metabolites in garlic were positively correlated with the pesticide stress dose. In short, the established in vivo tracking method is efficient and convenient. The features of simple operation, fast analysis, acceptable sensitivity, non-harmful or non-lethal to plants, available repeated and long-term monitoring of the same organism make it attractive for in vivo tracking assay, it is of great significance for the guidance of rational use of fipronil and protection of food safety.

Study on the environmental fate of three insecticides in garlic by in vivo sampling rate calibrated-solid phase microextraction-gas chromatography-mass spectrometry.

Traditional sample preparation methods for insecticide analysis are laborious and fatal to living organisms. In the work, an in vivo sampling rate calibrated-solid phase microextraction-gas chromatography-mass spectrometry method was established and successfully used for in vivo sampling and quantitative determination of three insecticides (hexachlorobenzene, fipronil and chlorfenapyr) by direct exposing micron-sized fiber in living garlic. Absorption, enrichment, migration and elimination behavior of insecticides in garlic were investigated. Bioaccumulative effects with obvious tissue differences were observed to all three insecticides, especially for chlorfenapyr. Bioconcentration factors (BCFs) ranging from 0.0342 to 1.0887 were obtained, and the closer to roots, the higher BCFs. The half-life of insecticides in garlic ranged from 0.43 to 0.96 d. In the first 24 h, 55.0% - 80.3% insecticides residues in garlic were eliminated with first-order elimination kinetics. The research provides in vivo insights into the environmental fates of insecticides in complex living system with minimized organism damage.

Phase I study of high-dose ascorbic acid with mFOLFOX6 or FOLFIRI in patients with metastatic colorectal cancer or gastric cancer.

BACKGROUND: Preclinical studies suggest synergistic effectiveness of ascorbic acid (AA, vitamin C) and cytotoxic agents in gastrointestinal malignancies. This phase 1 study aimed to establish the maximum tolerated dose (MTD) and recommended phase 2 dose (RP2D) of AA combined with mFOLFOX6 or FOLFIRI regimens in patients with metastatic colorectal cancer (mCRC) or gastric cancer (mGC). METHODS: In the dose-escalation phase, patients received AA (0.2-1.5 g/kg, 3-h infusion, once daily, days 1-3) with mFOLFOX6 or FOLFIRI in a 14-day cycle until the MTD was reached. In the speed-expansion phase, AA was administered at the MTD or at 1.5 g/kg if the MTD was not reached at a fixed rate of 0.6, 0.8 or 1 g/min. Pharmacokinetics and preliminary efficacy were also assessed. RESULTS: Thirty-six patients were enrolled. The MTD was not reached. The RP2D was established as AA at 1.5 g/kg/day, days 1-3, with mFOLFOX6 or FOLFIRI. No dose-limiting toxicity (DLT) was detected during dose escalation. The most common treatment-emergent adverse events (TRAEs) were sensory neuropathy (50%), nausea (38.9%), vomiting (36.1%) and neutropenia (27.8%). Grade 3-4 TRAEs were neutropenia (13.9%), sensory neuropathy (2.8%), vomiting (2.8%), diarrhea (2.8%) and leukopenia (2.8%). AA exposure was dose-proportional. The objective response rate was 58.3%, and the disease control rate was 95.8%. No difference in efficacy was found between mCRC patients with wild-type RAS/BRAF and mutant RAS or BRAF. CONCLUSIONS: The favorable safety profile and preliminary efficacy of AA plus mFOLFOX6/FOLFIRI support further evaluation of this combination in mCRC or mGC. TRIAL REGISTRATION: ClinicalTrial.gov Identifier: NCT02969681 .